Journal of Chest Surgery

The Korean Society for Thoracic and Cardiovascular Surgery (대한심장혈관흉부외과학회)
권호 표지

The Effects of Moxifloxacin in Endotoxin-induced Acute Lung Injury

내독소로 유도된 급성폐손상에서 Moxifloxacin의 효과

  • Baek, Jong Hyun (Department of Thoracic and Cardiovascular Surgery, College of Medicine, Yeungnam University) ;
  • Lee, Jang Hoon (Department of Thoracic and Cardiovascular Surgery, College of Medicine, Yeungnam University) ;
  • Lee, Jung Cheul (Department of Thoracic and Cardiovascular Surgery, College of Medicine, Yeungnam University) ;
  • Lee, Dong Hyup (Department of Thoracic and Cardiovascular Surgery, College of Medicine, Yeungnam University) ;
  • Moon, Yong Suk (Department of Anatomy, College of Medicine, Catholic University of Daegu) ;
  • Lee, Young Man (Department of Physiology, College of Medicine, Catholic University of Daegu)
  • 백종현 (영남대학교 의과대학 흉부외과학교실) ;
  • 이장훈 (영남대학교 의과대학 흉부외과학교실) ;
  • 이정철 (영남대학교 의과대학 흉부외과학교실) ;
  • 이동협 (영남대학교 의과대학 흉부외과학교실) ;
  • 문용석 (대구가톨릭대학교 의과대학 해부학교실) ;
  • 이영만 (대구가톨릭대학교 의과대학 생리학교실)
  • Received : 2008.10.16
  • Accepted : 2008.12.03
  • Published : 2009.02.05
Download PDF
⟨ Previous Next ⟩

Abstract

Background: The pathophysiology of acute respiratory distress syndrome with sepsis is acute lung injury (ALI) that's' caused by endotoxin (LPS). We evaluate effects of moxifloxacin on LPS-induced ALI in a rat model. Material and Method: The rats were divided into 3 groups as the control group (C), the LPS insult group (L), and the LPS+moxifloxacin treated group (L-M). ALI was induced by endotracheal instillation of E.coli LPS, then moxifloxacin was given in 30 minutes. Five hours later, we checked the lung weight/body weight ratio(the L/BW ratio), the protein & neutrophils in the bronchoalveolar lavage fluid (BALF), the myeloperoxidase (MPO) activity & the malondialdehyde (MDA) content, the expressions of cytosolic and secretory phospholipase $A_2$ (c, $sPLA_2$), and the morphology of the lung with using a light microscope. Result: The L/BW ratio, the protein content and the neutrophil count in the BALF, and the MPO activity and the MDA content in lung were significantly increased in group L compared to group C, and these factors were markedly decreased in group L-M compare to group L. The $cPLA_2$ expression and the $sPLA_2$ expression were increased in group L and the $cPLA_2$ expression was decreased in group L-M. Yet the $sPLA_2$ expression was not changed in group L-M. Morphologically, many inflammatory findings were observed in group L, but not in group L-M. Conclusion: Many of the inflammatory changes of ALI that were caused by LPS insult were ameliorated by moxifloxacin treatment.

배경: 패혈증에 동반된 급성호흡곤란증후군의 병태생리는 내독소에 의해 유발된 급성폐손상이다. 이 연구에서 우리는 내독소로 인해 유발된 급성 폐손상에서 moxifloxacin의 영향을 알아보고자 하였다. 대상 및 방법: 백서를 대조군(C), 내독소처리군(L), 내독소-moxifloxacin처리군(L-M)으로 나누었다. 대장균의 내독소를 기관 내 분무하여 급성폐손상을 유발하였고 L-M군에서는 내독소 분무 30분 후 moxifloxacin을 투여하였다. 내독소 투여 5시간 후 폐질량/체중비, 폐세척액 내의 단백함량, 폐세척액 내의 호중구 수, 폐장 내 myeloperoxidase (MPO) 활성도, 폐장 내 malondialdehyde (MDA) 함량을 측정하였고, 폐장 내 세포질형 $phospholipaseA_2$ ($cPLA_2$)와 분비형 $phospholipaseA_2$ ($sPLA_2$)의 발현을 관찰하고 광학현미경을 이용하여 형태학적인 분석을 시행하였다. 결과: 폐질량/체중비, 폐세척액 내의 단백함량, 폐세척액 내의 호중구 수, 폐장 내 myeloperoxidase (MPO) 활성도, 폐장 내 malondialdehyde (MDA) 함량은 L군에서 대조군 보다 유의하게 증가되어 있었고, L-M군은 L군보다 의미있게 낮은 것으로 나타났다. L군에서 $cPLA_2$와 $sPLA_2$의 발현은 증가되어 있었고 L-M군에서는 $cPLA_2$의 발현이 감소되어 있었다. 그러나 L-M군에서 $sPLA_2$의 발현은 L군과 차이가 없었다. 형태학적 분석으로 L군에서 많은 염증성 소견들을 관찰할 수 있었으나 L-M군에서는 관찰할 수 없었다. 결론: 내독소에 의해 유발된 급성폐손상의 많은 염증성 변화들이 moxifloxacin처리에 의해 소멸됨을 관찰할 수 있었다.

Keywords

References

  1. Bernard GR. Acute respiratory distress syndrome: a historical perspective. Am J Respir Crit Care Med 2005;172:798-806 https://doi.org/10.1164/rccm.200504-663OE
  2. Ware LB. Advances in the pathogenesis and treatment of the acute respiratory distress syndrome. Clinical Pulmonary Medicine 2003;10:208-18 https://doi.org/10.1097/01.cpm.0000080904.11193.27
  3. Mendez JL, Hubmayr RD. New insights into the pathology of acute respiratory failure. Curr Opin Crit Care 2005;11: 29-36 https://doi.org/10.1097/00075198-200502000-00005
  4. Carraway MS, Welty-Wolf KE, Miller DL, et al. Blockade of tissue factor: treatment for organ injury in established sepsis. Am J Respir Crit Care Med 2003;167:1200-9 https://doi.org/10.1164/rccm.200204-287OC
  5. Bulger EM, Maier RV. Lipid mediators in the pathophysiology of critical illness. Crit Care Med 2000;28:N27- 36 https://doi.org/10.1097/00003246-200004001-00004
  6. Pruzanski W, Vadas P, Browning J. Secretory non-pancreatic group II phospholipase A2: role in physiologic and inflammatory processes. J Lipid Mediat 1993;8:161-7
  7. Babior BM. Phagocytes and oxidative stress. Am J Med 2000;109:33-44 https://doi.org/10.1016/S0002-9343(00)00481-2
  8. Schaloske RH, Dennis EA. The phospholipase A2 superfamily and its group numbering system. Biochim Biophys Acta 2006;1761:1246-59 https://doi.org/10.1016/j.bbalip.2006.07.011
  9. McCord JM, Gao B, Leff J, Flores SC. Neutrophil-generated free radicals: possible mechanisms of injury in adult respiratory distress syndrome. Environ Health Perspect 1994;102 (Suppl 10):57-60
  10. Weiss T, Shalit I, Blau H, et al. Anti-inflammatory effects of moxifloxacin on activated human monocytic cells: inhibition of NF-kappaB and mitogen-activated protein kinase activation and of synthesis of proinflammatory cytokines. Antimicrob Agents Chemother 2004;48:1974-82 https://doi.org/10.1128/AAC.48.6.1974-1982.2004
  11. Choi JH, Song MJ, Kim SH, et al. Effect of moxifloxacin on production of proinflammatory cytokines from human peripheral blood mononuclear cells. Antimicrob Agents Chemother 2003;47:3704-7 https://doi.org/10.1128/AAC.47.12.3704-3707.2003
  12. van Helden HP, Kuijpers WC, Steenvoorden D, et al. Intratracheal aerosolization of endotoxin (LPS) in the rat: a comprehensive animal model to study adult (acute) respiratory distress syndrome. Exp Lung Res 1997;23:297-316 https://doi.org/10.3109/01902149709039228
  13. Lee WL, Downey GP. Neutrophil activation and acute lung injury. Curr Opin Crit Care 2001;7:1-7 https://doi.org/10.1097/00075198-200102000-00001
  14. Uriarte SM, Molestina RE, Miller RD, et al. Effects of fluoroquinolones on the migration of human phagocytes through Chlamydia pneumoniae-infected and tumor necrosis factor alpha-stimulated endothelial cells. Antimicrob Agents Chemother 2004;48:2538-43 https://doi.org/10.1128/AAC.48.7.2538-2543.2004
  15. Werber S, Shalit I, Fabian I, Steuer G, Weiss T, Blau H. Moxifloxacin inhibits cytokine-induced MAP kinase and NF-kappaB activation as well as nitric oxide synthesis in a human respiratory epithelial cell line. J Antimicrob Chemother 2005;55:293-300 https://doi.org/10.1093/jac/dkh525
  16. Blau H, Klein K, Shalit I, Halperin D, Fabian I. Moxifloxacin but not ciprofloxacin or azithromycin selectively inhibits IL-8, IL-6, ERK1/2, JNK, and NF-kappaB activation in a cystic fibrosis epithelial cell line. Am J Physiol Lung Cell Mol Physiol 2007;292:L343-52 https://doi.org/10.1152/ajplung.00030.2006
  17. Guo RF, Ward PA. Role of oxidants in lung injury during sepsis. Antioxid Redox Signal 2007;9:1991-2002 https://doi.org/10.1089/ars.2007.1785
  18. Kristof AS, Goldberg P, Laubach V, Hussain SN. Role of inducible nitric oxide synthase in endotoxin-induced acute lung injury. Am J Respir Crit Care Med 1998;158:1883-9 https://doi.org/10.1164/ajrccm.158.6.9802100
  19. Chakraborti S. Phospholipase A(2) isoforms: a perspective. Cell Signal 2003;15:637-65 https://doi.org/10.1016/S0898-6568(02)00144-4
  20. Levy R. The role of cytosolic phospholipase A2-alfa in regulation of phagocytic functions. Biochim Biophys Acta 2006;1761:1323-34 https://doi.org/10.1016/j.bbalip.2006.09.004
  21. Nagase T, Uozumi N, Ishii S, et al. Acute lung injury by sepsis and acid aspiration: a key role for cytosolic phospholipase A2. Nat Immunol 2000;1:42-6 https://doi.org/10.1038/76897
  22. Sun K, Qu X, Gao L, Myatt L. Dexamethasone fails to inhibit the induction of cytosolic phospholipase A(2) expression by interleukin-1beta in cultured primary human amnion fibroblasts. Placenta 2006;27:164-70 https://doi.org/10.1016/j.placenta.2005.03.004
  23. Chenevier-Gobeaux C, Simonneau C, Therond P, et al. Implication of cytosolic phospholipase A2 (cPLA2) in the regulation of human synoviocyte NADPH oxidase (Nox2) activity. Life Sci 2007;81:1050-8. https://doi.org/10.1016/j.lfs.2007.08.018
  24. Adhikari N, Burns KE, Meade MO. Pharmacologic treatments for acute respiratory distress syndrome and acute lung injury: systematic review and meta-analysis. Treat Respir Med 2004;3:307-28 https://doi.org/10.2165/00151829-200403050-00005
  25. Bellido-Reyes YA, Akamatsu H, Kojima K, Arai H, Tanaka H, Sunamori M. Cytosolic phospholipase A2 inhibition attenuates ischemia reperfusion injury in an isolated rat lung model. Transplantation 2006;81:1700-7 https://doi.org/10.1097/01.tp.0000226065.82066.21